FDA Approved: REBLOZYL — Original Application (Celgene Corporation)

View source ↗

Summary

FDA approved Reblozyl (luspatercept) in the original application for adults with transfusion-dependent anemia due to myelodysplastic syndromes with ring siderob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Myelodysplastic Syndrome with Ring Sideroblasts

Drugs mentioned

• REBLOZYL (LUSPATERCEPT)

Snippet

ORIG AP for REBLOZYL (LUSPATERCEPT)